{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T11:59:48Z","timestamp":1720526388665},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40257-016-0200-x","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T08:36:52Z","timestamp":1464856612000},"page":"463-474","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of Pain Associated with Selected Conditions in Dermatology"],"prefix":"10.1007","volume":"17","author":[{"given":"Feras M.","family":"Al-Ghazawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele L.","family":"Ramien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Brassard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Beecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"8","key":"200_CR1","first-page":"704","volume":"7","author":"D Nashan","year":"2009","unstructured":"Nashan D, Meiss F, Gralow I. Pain: basics and relevance in dermatology. J Dtsch Dermatol Ges. 2009;7(8):704\u201317.","journal-title":"J Dtsch Dermatol Ges."},{"key":"200_CR2","doi-asserted-by":"crossref","unstructured":"Bhullar S, Gill JS, Beecker J. Gaps in pain management in dermatology: a needs assessment from Canada. J Am Acad Dermatol. 2014;71(6):1258\u20139 e2.","DOI":"10.1016\/j.jaad.2014.04.024"},{"key":"200_CR3","unstructured":"WHO. Cancer pain relief: with a guide to opioid availability, 2nd ed. Geneva; 1996."},{"issue":"1","key":"200_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ajgsup.2014.3","volume":"2","author":"CE Argoff","year":"2014","unstructured":"Argoff CE, Viscusi ER. The use of opioid analgesics for chronic pain: minimizing the risk for harm. Am J Gastroenterol. 2014;2(1):3\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"200_CR5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain-misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253\u201363.","journal-title":"N Engl J Med"},{"key":"200_CR6","unstructured":"Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(6):514\u20137, e202\u20135."},{"key":"200_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","volume":"2","author":"U Wollina","year":"2007","unstructured":"Wollina U. Pyoderma gangrenosum\u2013a review. Orphanet J Rare Dis. 2007;2:19.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"200_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","volume":"13","author":"I Ahronowitz","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191\u2013211.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"200_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1468-3083.2000.00019.x","volume":"14","author":"U Wollina","year":"2000","unstructured":"Wollina U, Karamfilov T. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix. J Eur Acad Dermatol Venereol. 2000;14(3):187\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"200_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1590\/S0365-05962011000600022","volume":"86","author":"WA Vieira","year":"2011","unstructured":"Vieira WA, Barbosa LR, Martin LM. Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum. An Bras Dermatol. 2011;86(6):1193\u20136.","journal-title":"An Bras Dermatol."},{"key":"200_CR11","doi-asserted-by":"crossref","unstructured":"Tremaine WJ. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD. Inflamm Bowel Dis. 1998;4(1):68\u20139 (discussion 73).","DOI":"10.1097\/00054725-199802000-00010"},{"key":"200_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen PR. Sweet\u2019s syndrome\u2013a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"200_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0049-0172(88)90016-9","volume":"17","author":"LW Moreland","year":"1988","unstructured":"Moreland LW, Brick JE, Kovach RE, DiBartolomeo AG, Mullins MC. Acute febrile neutrophilic dermatosis (Sweet syndrome): a review of the literature with emphasis on musculoskeletal manifestations. Semin Arthritis Rheum. 1988;17(3):143\u201353.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"200_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000205067","volume":"84","author":"JL Bello Lopez","year":"1990","unstructured":"Bello Lopez JL, Fonseca E, Manso F. Sweet\u2019s syndrome during the chronic phase of chronic myeloid leukaemia. Acta Haematol. 1990;84(4):207\u20138.","journal-title":"Acta Haematol"},{"issue":"2 Pt 1","key":"200_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","volume":"13","author":"JP Callen","year":"1985","unstructured":"Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1985;13(2 Pt 1):193\u2013200.","journal-title":"J Am Acad Dermatol"},{"key":"200_CR16","doi-asserted-by":"crossref","unstructured":"Armitage M, Roberts J. Caring for patients with leg ulcers and an underlying vasculitic condition. Br J Community Nurs. 2004;Suppl:S16\u201322.","DOI":"10.12968\/bjcn.2004.9.Sup5.17250"},{"issue":"5","key":"200_CR17","first-page":"695","volume":"75","author":"RA Schwartz","year":"2007","unstructured":"Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007;75(5):695\u2013700.","journal-title":"Am Fam Physician"},{"issue":"6","key":"200_CR18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1155\/1997\/434989","volume":"11","author":"JK Marshall","year":"1997","unstructured":"Marshall JK, Irvine EJ. Successful therapy of refractory erythema nodosum associated with Crohn\u2019s disease using potassium iodide. Can J Gastroenterol. 1997;11(6):501\u20132.","journal-title":"Can J Gastroenterol."},{"issue":"2","key":"200_CR19","first-page":"75","volume":"37","author":"MC Shen","year":"2004","unstructured":"Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect. 2004;37(2):75\u201381.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"200_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","volume":"84","author":"P Sampathkumar","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274\u201380.","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"200_CR21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199403313301304","volume":"330","author":"MJ Wood","year":"1994","unstructured":"Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7\u00a0days or 21\u00a0days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994;330(13):896\u2013900.","journal-title":"N Engl J Med"},{"key":"200_CR22","doi-asserted-by":"crossref","unstructured":"Doble S. Management of patients with post-herpetic neuralgia. Nurs Stand. 2008;22(39):49\u201356 (quiz 8, 60).","DOI":"10.7748\/ns2008.06.22.39.49.c6569"},{"key":"200_CR23","doi-asserted-by":"crossref","unstructured":"Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002;94(3):694\u2013700 (table of contents).","DOI":"10.1097\/00000539-200203000-00040"},{"issue":"5","key":"200_CR24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1213\/ANE.0b013e3181d5adaf","volume":"110","author":"A Kanai","year":"2010","unstructured":"Kanai A, Okamoto T, Suzuki K, Niki Y, Okamoto H. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia. Anesth Analg. 2010;110(5):1457\u201360.","journal-title":"Anesth Analg"},{"issue":"1\u20132","key":"200_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","volume":"104","author":"F Boureau","year":"2003","unstructured":"Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104(1\u20132):323\u201331.","journal-title":"Pain"},{"issue":"5","key":"200_CR26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2165\/00003495-200059050-00007","volume":"59","author":"GE Kanazi","year":"2000","unstructured":"Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs. 2000;59(5):1113\u201326.","journal-title":"Drugs."},{"issue":"1","key":"200_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/15360288.2010.547561","volume":"25","author":"VM Jones","year":"2011","unstructured":"Jones VM, Moore KA, Peterson DM. Capsaicin 8\u00a0% topical patch (Qutenza)\u2013a review of the evidence. J Pain Palliat Care Pharmacother. 2011;25(1):32\u201341.","journal-title":"J Pain Palliat Care Pharmacother."},{"issue":"1","key":"200_CR28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2165\/00003495-199039010-00005","volume":"39","author":"JA Burgess","year":"1990","unstructured":"Burgess JA, Johnson BD, Sommers E. Pharmacological management of recurrent oral mucosal ulceration. Drugs. 1990;39(1):54\u201365.","journal-title":"Drugs."},{"key":"200_CR29","unstructured":"McBride DR. Management of aphthous ulcers. Am Fam Physician. 2000;62(1):149\u201354, 60."},{"issue":"2","key":"200_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMcp054630","volume":"355","author":"C Scully","year":"2006","unstructured":"Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006;355(2):165\u201372.","journal-title":"N Engl J Med."},{"key":"200_CR31","doi-asserted-by":"crossref","unstructured":"Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52(1):61\u201377, viii.","DOI":"10.1016\/j.cden.2007.10.002"},{"issue":"3","key":"200_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/tcrm.2006.2.3.251","volume":"2","author":"DJ Harris","year":"2006","unstructured":"Harris DJ. Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manag. 2006;2(3):251\u20138.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"200_CR33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s005209900076","volume":"8","author":"NS Turhal","year":"2000","unstructured":"Turhal NS, Erdal S, Karacay S. Efficacy of treatment to relieve mucositis-induced discomfort. Support Care Cancer. 2000;8(1):55\u20138.","journal-title":"Support Care Cancer"},{"issue":"5","key":"200_CR34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820\u201331.","journal-title":"Cancer"},{"key":"200_CR35","doi-asserted-by":"crossref","unstructured":"Lalla RV, Peterson DE. Oral mucositis. Dent Clin N Am. 2005;49(1):167\u201384, ix.","DOI":"10.1016\/j.cden.2004.07.009"},{"issue":"4","key":"200_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0196-0709(83)80072-6","volume":"4","author":"M Navazesh","year":"1983","unstructured":"Navazesh M, Ship II. Xerostomia: diagnosis and treatment. Am J Otolaryngol. 1983;4(4):283\u201392.","journal-title":"Am J Otolaryngol"},{"key":"200_CR37","unstructured":"Perez-Perez LC. General features and treatment of notalgia paresthetica. Skinmed. 2011;9(6):353\u20138 (quiz 9)."},{"issue":"1","key":"200_CR38","first-page":"37","volume":"81","author":"JE Lane","year":"2008","unstructured":"Lane JE, McKenzie JT, Spiegel J. Brachioradial pruritus: a case report and review of the literature. Cutis. 2008;81(1):37\u201340.","journal-title":"Cutis"},{"issue":"4","key":"200_CR39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/aim.20.4.186","volume":"20","author":"A Stellon","year":"2002","unstructured":"Stellon A. Neurogenic pruritus: an unrecognised problem? A retrospective case series of treatment by acupuncture. Acupunct Med. 2002;20(4):186\u201390.","journal-title":"Acupunct Med"},{"issue":"11","key":"200_CR40","first-page":"605","volume":"109","author":"BS Richardson","year":"2009","unstructured":"Richardson BS, Way BV, Speece AJ 3rd. Osteopathic manipulative treatment in the management of notalgia paresthetica. J Am Osteopath Assoc. 2009;109(11):605\u20138.","journal-title":"J Am Osteopath Assoc"},{"issue":"6","key":"200_CR41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1468-3083.2009.03479.x","volume":"24","author":"L Perez-Perez","year":"2010","unstructured":"Perez-Perez L, Allegue F, Fabeiro JM, Caeiro JL, Zulaica A. Notalgia paresthesica successfully treated with narrow-band UVB: report of five cases. J Eur Acad Dermatol Venereol. 2010;24(6):730\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"200_CR42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0190-9622(98)70552-3","volume":"38","author":"V Goulden","year":"1998","unstructured":"Goulden V, Toomey PJ, Highet AS. Successful treatment of notalgia paresthetica with a paravertebral local anesthetic block. J Am Acad Dermatol. 1998;38(1):114\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"200_CR43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2007.02256.x","volume":"21","author":"MP Loosemore","year":"2007","unstructured":"Loosemore MP, Bordeaux JS, Bernhard JD. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy. J Eur Acad Dermatol Venereol. 2007;21(10):1440\u20131.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"200_CR44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1346-8138.2007.00279.x","volume":"34","author":"E Savk","year":"2007","unstructured":"Savk E, Savk O, Sendur F. Transcutaneous electrical nerve stimulation offers partial relief in notalgia paresthetica patients with a relevant spinal pathology. J Dermatol. 2007;34(5):315\u20139.","journal-title":"J Dermatol"},{"issue":"2","key":"200_CR45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/2013.jamadermatol.646","volume":"149","author":"TJ Poterucha","year":"2013","unstructured":"Poterucha TJ, Murphy SL, Davis MD, Sandroni P, Rho RH, Warndahl RA, et al. Topical amitriptyline-ketamine for the treatment of brachioradial pruritus. JAMA Dermatol. 2013;149(2):148\u201350.","journal-title":"JAMA Dermatol."},{"issue":"5","key":"200_CR46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamadermatol.2013.170","volume":"149","author":"MS Ally","year":"2013","unstructured":"Ally MS, Gamba CS, Peng DH, Tang JY. The use of aprepitant in brachioradial pruritus. JAMA Dermatol. 2013;149(5):627\u20138.","journal-title":"JAMA Dermatol."},{"issue":"2","key":"200_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaad.2015.04.059","volume":"74","author":"NK Shumway","year":"2016","unstructured":"Shumway NK, Cole E, Fernandez KH. Neurocutaneous disease: neurocutaneous dysesthesias. J Am Acad Dermatol. 2016;74(2):215\u201328.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"200_CR48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ogc.2014.05.005","volume":"41","author":"M Shah","year":"2014","unstructured":"Shah M, Hoffstetter S. Vulvodynia. Obstet Gynecol Clin N Am. 2014;41(3):453\u201364.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"5","key":"200_CR49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1529-8019.2010.01353.x","volume":"23","author":"D Hartmann","year":"2010","unstructured":"Hartmann D. Chronic vulvar pain from a physical therapy perspective. Dermatol Ther. 2010;23(5):505\u201313.","journal-title":"Dermatol Ther"},{"issue":"9","key":"200_CR50","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924\u201335.","journal-title":"Lancet Neurol"},{"issue":"4","key":"200_CR51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpain.2004.09.009","volume":"9","author":"A Yucel","year":"2005","unstructured":"Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain. 2005;9(4):407\u201316.","journal-title":"Eur J Pain"},{"issue":"2","key":"200_CR52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2010.09.005","volume":"152","author":"JH Vranken","year":"2011","unstructured":"Vranken JH, Hollmann MW, van der Vegt MH, Kruis MR, Heesen M, Vos K, et al. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial. Pain. 2011;152(2):267\u201373.","journal-title":"Pain"},{"issue":"3","key":"200_CR53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/clpt.1990.33","volume":"47","author":"R Kishore-Kumar","year":"1990","unstructured":"Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47(3):305\u201312.","journal-title":"Clin Pharmacol Ther"},{"issue":"1\u20133","key":"200_CR54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","volume":"133","author":"TJ Nurmikko","year":"2007","unstructured":"Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain. 2007;133(1\u20133):210\u201320.","journal-title":"Pain"},{"issue":"2","key":"200_CR55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.56.2.184","volume":"56","author":"K Vestergaard","year":"2001","unstructured":"Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56(2):184\u201390.","journal-title":"Neurology."},{"issue":"5","key":"200_CR56","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","volume":"152","author":"JS Kim","year":"2011","unstructured":"Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152(5):1018\u201323.","journal-title":"Pain"},{"issue":"3","key":"200_CR57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","volume":"64","author":"D Ranoux","year":"2008","unstructured":"Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64(3):274\u201383.","journal-title":"Ann Neurol."},{"issue":"2","key":"200_CR58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.410370216","volume":"37","author":"MC Rowbotham","year":"1995","unstructured":"Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995;37(2):246\u201353.","journal-title":"Ann Neurol."},{"issue":"7","key":"200_CR59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.6061\/clinics\/2013(07)25","volume":"68","author":"MJ Teixeira","year":"2013","unstructured":"Teixeira MJ, Okada M, Moscoso AS, Puerta MY, Yeng LT, Galhardoni R, et al. Methadone in post-herpetic neuralgia: a pilot proof-of-concept study. Clinics (Sao Paulo). 2013;68(7):1057\u201360.","journal-title":"Clinics (Sao Paulo)."},{"issue":"3","key":"200_CR60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archderm.134.3.327","volume":"134","author":"D Hoss","year":"1998","unstructured":"Hoss D, Segal S. Scalp dysesthesia. Arch Dermatol. 1998;134(3):327\u201330.","journal-title":"Arch Dermatol"},{"issue":"11","key":"200_CR61","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-4632.2011.05158.x","volume":"52","author":"E Sarifakioglu","year":"2013","unstructured":"Sarifakioglu E, Onur O. Women with scalp dysesthesia treated with pregabalin. Int J Dermatol. 2013;52(11):1417\u20138.","journal-title":"Int J Dermatol"},{"issue":"Suppl 1","key":"200_CR62","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.4103\/0975-7406.155899","volume":"7","author":"S Jimson","year":"2015","unstructured":"Jimson S, Rajesh E, Krupaa RJ, Kasthuri M. Burning mouth syndrome. J Pharm Bioallied Sci. 2015;7(Suppl 1):S194\u20136.","journal-title":"J Pharm Bioallied Sci."},{"issue":"1","key":"200_CR63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0034-1378138","volume":"19","author":"I Miziara","year":"2015","unstructured":"Miziara I, Chagury A, Vargas C, Freitas L, Mahmoud A. Therapeutic options in idiopathic burning mouth syndrome: literature review. Int Arch Otorhinolaryngol. 2015;19(1):86\u20139.","journal-title":"Int Arch Otorhinolaryngol."},{"issue":"Suppl 1","key":"200_CR64","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.4103\/0975-7406.137255","volume":"6","author":"R Aravindhan","year":"2014","unstructured":"Aravindhan R, Vidyalakshmi S, Kumar MS, Satheesh C, Balasubramanium AM, Prasad VS. Burning mouth syndrome: a review on its diagnostic and therapeutic approach. J Pharm Bioallied Sci. 2014;6(Suppl 1):S21\u20135.","journal-title":"J Pharm Bioallied Sci."},{"issue":"5","key":"200_CR65","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.4317\/medoral.16942","volume":"16","author":"E Lopez-D\u2019alessandro","year":"2011","unstructured":"Lopez-D\u2019alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011;16(5):e635\u201340.","journal-title":"Med Oral Patol Oral Cir Bucal."},{"issue":"1","key":"200_CR66","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1038\/sj.bdj.2010.582","volume":"209","author":"GA Scardina","year":"2010","unstructured":"Scardina GA, Ruggieri A, Provenzano F, Messina P. Burning mouth syndrome: is acupuncture a therapeutic possibility? Br Dent J. 2010;209(1):E2.","journal-title":"Br Dent J"},{"issue":"10","key":"200_CR67","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.diii.2013.08.002","volume":"94","author":"D Leclercq","year":"2013","unstructured":"Leclercq D, Thiebaut JB, Heran F. Trigeminal neuralgia. Diagn Interv Imaging. 2013;94(10):993\u20131001.","journal-title":"Diagn Interv Imaging."},{"key":"200_CR68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/TCRM.S37592","volume":"11","author":"N Montano","year":"2015","unstructured":"Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015;11:289\u201399.","journal-title":"Ther Clin Risk Manag"},{"key":"200_CR69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1129-2377-14-72","volume":"14","author":"Y Hu","year":"2013","unstructured":"Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, et al. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain. 2013;14:72.","journal-title":"J Headache Pain."},{"issue":"1","key":"200_CR70","first-page":"1","volume":"8","author":"F Falaki","year":"2014","unstructured":"Falaki F, Nejat AH, Dalirsani Z. The effect of low-level laser therapy on trigeminal neuralgia: a review of literature. J Dent Res Dent Clin Dent Prospects. 2014;8(1):1\u20135.","journal-title":"J Dent Res Dent Clin Dent Prospects."},{"issue":"2","key":"200_CR71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-2982.2007.01483.x","volume":"28","author":"M Obermann","year":"2008","unstructured":"Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28(2):174\u201381.","journal-title":"Cephalalgia"},{"issue":"6","key":"200_CR72","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","volume":"48","author":"G Lunardi","year":"1997","unstructured":"Lunardi G, Leandri M, Albano C, Cultrera S, Fracassi M, Rubino V, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48(6):1714\u20137.","journal-title":"Neurology."},{"issue":"12","key":"200_CR73","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archneur.1980.00500610048007","volume":"37","author":"GH Fromm","year":"1980","unstructured":"Fromm GH, Terrence CF, Chattha AS, Glass JD. Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol. 1980;37(12):768\u201371.","journal-title":"Arch Neurol"},{"issue":"4","key":"200_CR74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bja\/ael180","volume":"97","author":"A Kanai","year":"2006","unstructured":"Kanai A, Suzuki A, Kobayashi M, Hoka S. Intranasal lidocaine 8\u00a0% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559\u201363.","journal-title":"Br J Anaesth"},{"issue":"7","key":"200_CR75","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.55.7.964","volume":"55","author":"I Gilron","year":"2000","unstructured":"Gilron I, Booher SL, Rowan MS, Smoller MS, Max MB. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology. 2000;55(7):964\u201371.","journal-title":"Neurology."},{"issue":"1","key":"200_CR76","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","volume":"18","author":"SH Sindrup","year":"2002","unstructured":"Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18(1):22\u20137.","journal-title":"Clin J Pain"},{"issue":"6","key":"200_CR77","first-page":"30","volume":"16","author":"H Liu","year":"2010","unstructured":"Liu H, Li H, Xu M, Chung KF, Zhang SP. A systematic review on acupuncture for trigeminal neuralgia. Altern Ther Health Med. 2010;16(6):30\u20135.","journal-title":"Altern Ther Health Med"},{"issue":"6","key":"200_CR78","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2004.01.038","volume":"50","author":"SU Monrad","year":"2004","unstructured":"Monrad SU, Terrell JE, Aronoff DM. The trigeminal trophic syndrome: an unusual cause of nasal ulceration. J Am Acad Dermatol. 2004;50(6):949\u201352.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"200_CR79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0196-0709(94)90009-4","volume":"15","author":"JW Goodnight","year":"1994","unstructured":"Goodnight JW, Calcaterra T. Trigeminal trophic syndrome: a report of two cases and review. Am J Otolaryngol. 1994;15(3):219\u201322.","journal-title":"Am J Otolaryngol"},{"issue":"6","key":"200_CR80","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2340\/00015555-0953","volume":"90","author":"S Nakamizo","year":"2010","unstructured":"Nakamizo S, Miyachi Y, Kabashima K. Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1\u00a0% topical tacrolimus and gabapentin. Acta Derm Venereol. 2010;90(6):654\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"200_CR81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4065\/83.4.502","volume":"83","author":"J Fruhauf","year":"2008","unstructured":"Fruhauf J, Schaider H, Massone C, Kerl H, Mullegger RR. Carbamazepine as the only effective treatment in a 52-year-old man with trigeminal trophic syndrome. Mayo Clin Proc. 2008;83(4):502\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"200_CR82","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archderm.1979.04010090060029","volume":"115","author":"AY Finlay","year":"1979","unstructured":"Finlay AY. Trigeminal trophic syndrome. Arch Dermatol. 1979;115(9):1118.","journal-title":"Arch Dermatol"},{"issue":"6","key":"200_CR83","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0190-9622(83)80015-2","volume":"8","author":"EE Duke","year":"1983","unstructured":"Duke EE. Clinical experience with pimozide: emphasis on its use in postherpetic neuralgia. J Am Acad Dermatol. 1983;8(6):845\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"200_CR84","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1346-8138.1991.tb03142.x","volume":"18","author":"J Tada","year":"1991","unstructured":"Tada J, Ueda M, Abe Y, Fujiwara H, Arakawa K, Arata J. Trigeminal trophic syndrome\u2013a report of three patients. J Dermatol. 1991;18(10):613\u20135.","journal-title":"J Dermatol"},{"issue":"5","key":"200_CR85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2133.1983.tb01063.x","volume":"108","author":"W Westerhof","year":"1983","unstructured":"Westerhof W, Bos JD. Trigeminal trophic syndrome: a successful treatment with transcutaneous electrical stimulation. Br J Dermatol. 1983;108(5):601\u20134.","journal-title":"Br J Dermatol"},{"issue":"1","key":"200_CR86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1440-0960.2009.00613.x","volume":"52","author":"AM Kurien","year":"2011","unstructured":"Kurien AM, Damian DL, Moloney FJ. Trigeminal trophic syndrome treated with thermoplastic occlusion. Australas J Dermatol. 2011;52(1):e1\u20134.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"200_CR87","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.tvir.2014.11.004","volume":"17","author":"ST Valdovinos","year":"2014","unstructured":"Valdovinos ST, Landry GJ. Raynaud syndrome. Tech Vasc Interv Radiol. 2014;17(4):241\u20136.","journal-title":"Tech Vasc Interv Radiol."},{"issue":"4","key":"200_CR88","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archdermatol.2011.1144","volume":"148","author":"L Smith","year":"2012","unstructured":"Smith L, Polsky D, Franks AG Jr. Botulinum toxin-A for the treatment of Raynaud syndrome. Arch Dermatol. 2012;148(4):426\u20138.","journal-title":"Arch Dermatol"},{"issue":"9","key":"200_CR89","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","volume":"40","author":"B Coleiro","year":"2001","unstructured":"Coleiro B, Marshall SE, Denton CP, Howell K, Blann A, Welsh KI, et al. Treatment of Raynaud\u2019s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford). 2001;40(9):1038\u201343.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"200_CR90","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kel038","volume":"45","author":"G Milio","year":"2006","unstructured":"Milio G, Corrado E, Genova C, Amato C, Raimondi F, Almasio PL, et al. Iloprost treatment in patients with Raynaud\u2019s phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Rheumatology (Oxford). 2006;45(8):999\u20131004.","journal-title":"Rheumatology (Oxford)"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0200-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:54:37Z","timestamp":1718614477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0200-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0200-x","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}